Detalles de la búsqueda
1.
Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts.
Am J Pathol
; 188(12): 2890-2901, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30273606
2.
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
Bioorg Med Chem
; 22(12): 3187-203, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24794746
3.
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice.
iScience
; 25(5): 104287, 2022 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35573198
4.
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1.
J Steroid Biochem Mol Biol
; 192: 105115, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438723
5.
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity.
Mol Cancer Ther
; 18(1): 28-38, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301864
6.
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.
Sci Rep
; 5: 12007, 2015 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137992
Resultados
1 -
6
de 6
1
Próxima >
>>